MediFind Announced as Finalist for Reuter’s Pharma Awards USA: Most Valuable Service or Digital Therapy

article thumbnail

The Reuters Events’ Pharma Awards USA focus on what really matters: value for patients and customers. Recognizing innovative and meaningful approaches: this is the work worth applauding. The awards focus on initiatives that deliver outcomes, restore pharma’s reputation and celebrate real achievements.

Specifically, the Most Valuable Service or Digital Therapy category focuses on initiatives that go beyond the pill, providing a holistic service or solution that provides significant benefit to patients.

The formal awards ceremony is scheduled for December 7-9, 2020. Read more about the award and the other finalists here.

Relevant Articles

  • What is expanded access (compassionate use)?

    Expanded access, sometimes called “compassionate use” allows patients access to investigational drugs (not yet approved by the FDA) outside of clinical trials when alternatives are not available. Investigation drugs are offered during clinical trials, but when they are used outside of a trial, the action is labeled “compassionate use.” The FDA offers more information on…

    article thumbnail
  • Alveolar Soft Part Sarcoma Treatments

    Receiving a diagnosis of Alveolar Soft Part Sarcoma (ASPS) can be confusing and isolating. Because this is an ultra-rare soft tissue cancer that often affects younger adults and adolescents, finding reliable information can be challenging. The condition typically presents as a painless lump in the leg or arm, but its tendency to spread (metastasize) to the lungs or brain adds a layer of complexity to daily life and long-term planning. Navigating this diagnosis requires patience and a strong support system. Treatment is essential to control the growth of the tumor and prevent it from spreading further. While the slow-growing nature…

    article thumbnail
  • Your Go-To Guide for Decoding Medical Bills 

    Medical bills can be confusing, but there are things you can do to spot errors and avoid paying unnecessary charges.

    article thumbnail